Scientists in Africa have begun trials of a malaria vaccine which, if successful, could save millions of lives on the continent and around the world. The mosquirix vaccine also known as RDSS is being tested in Africa's biggest ever clinical trial, spanning seven nations, and involving over 16 thousand children.
Reports say more than five thousand have already undergone preliminary trials since testing began in 2003.
The vaccine is the result of a partnership between GlaxoSmithKline the British drug manufacturer, and US-based path Malaria Vaccine Imitative which is funded by the Bill and Melinda Gates Foundation along with clinics and research centres in Africa.
BoG's $260 million building: It was Ato Forson who first proposed 'sell-and-leas...
'We have to do soul-searching' — Mahama orders nationwide flood assessment
Court orders woman beater to pay GHS5,000 compensation to midwife at Tema Commun...
Over 12,000 women living with obstetric fistula in Ghana — Asokwa MP
Mahama secures 1,840 farm equipment deal from Belarus
Titus Glover slams Mahama’s flood report directive, calls it “waste of energy an...
We have increased posting of doctors from 12 to 100 to underserved regions in 20...
'You had the effrontery to call me struggling lawyer, you won't come back to pow...
Belarus manufacturers to storm Ghana next week after President's visit
Government to offer tax incentives for factories located outside Accra
